Tax-exempt hospitals in the 340B drug savings program provided $56.1 billion in total benefits to their communities in 2016, the most recent year for which data is available, according to an analysis released today by the AHA. “Hospitals and health systems of all kinds and sizes are hard at work delivering a wide variety of benefits tailored to meet the needs of their diverse communities,” said AHA Executive Vice President Tom Nickels. “This report demonstrates once again the significant value that the 340B drug savings program allows eligible hospitals to provide for their communities through a range of important programs and services, many of which would otherwise be unavailable.” Funded by drug company discounts, not federal dollars, the 340B program was created by Congress more than 25 years ago “to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”

Headline
The Health Resources and Services Administration Maternal and Child Health Bureau has announced grant opportunities available supporting maternal and child…
Headline
Hospital and health system leaders gathered June 17 and 18 in Washington, D.C., for U.S. News & World Report’s Healthcare of Tomorrow Conference, focusing…
Headline
Sarah Stella, M.D., director of Denver Health’s Housing Outreach, Partnerships and Engagement program, or HOPE, reveals how Denver Health is helping some of…
Headline
The AHA is launching a new learning collaborative, Adopting Digital Tools for Better Aging Care, which is part of the West Health Accelerator at AHA’s Health…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…